Skip to main content
Premium Trial:

Request an Annual Quote

Purigen Biosystems Signs Distribution Deal for Nucleic Acid Extraction System in Switzerland

NEW YORK — Purigen Biosystems said on Tuesday that it has signed a distribution agreement for its automated nucleic acid extraction system in Switzerland with Bucher Biotec.

Purigen's Ionic Purification System uses isotachophoresis to extract nucleic acids from a wide range of sample types including cultured or sorted cells and formalin-fixed, paraffin-embedded tissues, Purigen said. The small benchtop instrument was launched in the US in 2019 and received CE marking in 2021.

Under the terms of the deal, Bucher Biotec will have the exclusive rights to distribute, service, and support the system in Switzerland. Additional terms were not disclosed.

Earlier this month, Pleasanton, California-based Purigen partnered with Proteigene to distribute the system in France. It also signed on GC Biotech in April to sell the system in the Benelux countries.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.